Security key
P8696W104
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 3,034,321
- Share change
- 0
- Total reported value
- $336,038,595
- Price per share
- $64.66
- Number of holders
- 2
Report period
Q1 2025
Institutions
2
Top holders
2
SVA full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
SINOVAC BIOTECH LTD SEC filings
SINOVAC BIOTECH LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP P8696W104
Recent filing periods:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital IX, LLC |
13D/G
|
— |
6.3%
|
4,539,456
|
$293,522,587 | $0 | 17 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.8%
|
2,718,735
|
$333,996,595 | — | 31 Dec 2024 | |
| Neumann Advisory Hong Kong Ltd |
13F
|
Company |
0.44%
|
315,586
|
$2,042,000 | — | 31 Dec 2024 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q1 2025
As of 31 Mar 2025,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,034,321 shares.
The largest 2 holders included
ORBIMED ADVISORS LLC and Neumann Advisory Hong Kong Ltd.
This page lists
2
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
2
Q1 2025 holders
2
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.